KKR & Co Inc. is set to acquire a majority stake in India’s Healthcare Global Enterprises Ltd. from CVC Capital Partners at a ...
US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an ...
KKR & Co. Inc. (NYSE:KKR) entered into definitive agreements with CVC, a private markets manager, to become the largest ...
KKR has agreed to acquire a majority stake in Healthcare Global Enterprises, an India-based oncology hospital chain, for $400 million. The seller is CVC Capital Partners. Dr. BS Ajaikumar, founder of ...
智通财经APP获悉,私募股权巨头KKR(KKR.US)将以4亿美元的价格从CVC Capital Partners手中收购印度Healthcare Global Enterprises ...
2 小时
News Medical on MSNFDA warns against HCG weight-loss productsAnyone who has ever been on a diet knows there are sensible ways to lose weight, including eating a balanced diet and ...
私募巨头KKR(KKR.US)宣布以4亿美元的价格收购印度Healthcare Global Enterprises Ltd.(HCG)多数股权,成为其最大股东与唯一运营商。HCG在声明中表示,KKR将以每股445卢比的价格从CVC Capital Partners手中购买至多54%的股权,随后还将向公众股东公开收购更多股票,最终可能使KKR持有多达77%的股份,全面掌控HCG在印度的业务。
Healthcare Global Enterprises (HCG) rose 2.83% to Rs 514.15 after the company said KKR, a prominent global investment firm, will acquire a controlling stake in oncology hospital chain.
Global investment firm KKR has signed definitive agreements to acquire a controlling stake in Healthcare Global Enterprises ...
随着阿达尼集团、黑石集团等巨头纷纷布局医疗行业,HCG的收购案背后隐藏着一场全球资本的围猎。在调整资源、追逐利润的过程中,谁将成为这场医药投资游戏的赢家?每张病床背后,都是资本的狂欢,都是无形的博弈。
Global investment firm KKR has agreed to acquire a controlling stake in Bengaluru-based Healthcare Global Enterprises (HCG) ...
私募股权机构KKR集团周一宣布,已签署最终协议,将以每股445印度卢比(约合37.20元人民币)的价格收购CVC Asia V机构54%的股份,以此收购印度领先的医疗保健公司Healthcare Global Enterprises(HCG)的多数股权。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果